Management of Wilms tumor: current standard of care

Geoffrey Sonn1, Linda M D Shortliffe

  • 1Stanford University Medical Center, Stanford, CA 94305-5118, USA.

Insights

Childhood Wilms tumor survival has dramatically improved to 90% due to multidisciplinary therapy. Current research focuses on reducing treatment-related morbidity, such as organ damage and secondary cancers.

Area of Science:

  • Pediatric Oncology
  • Pediatric Surgery
  • Medical Malignancies

Background:

  • Wilms tumor is the most common kidney cancer in children.
  • Historically, survival rates were low (approx. 30% in the 1930s).
  • Multidisciplinary therapy has significantly improved survival to about 90%.

Purpose of the Study:

  • To compare the differing management strategies for Wilms tumor in Europe and the US.
  • To highlight the current focus on reducing treatment-related morbidity.
  • To assess the current role of laparoscopic surgery in Wilms tumor management.

Main Methods:

  • Comparison of European (neoadjuvant chemotherapy followed by surgery) and US (primary surgery followed by chemotherapy) protocols.
  • Review of outcomes and survival rates associated with different management strategies.
  • Identification of significant treatment complications and current surgical limitations.

Main Results:

  • Both European and US protocols achieve similar, excellent overall survival rates for Wilms tumor.
  • Treatment complications include cardiomyopathy, renal failure, and secondary malignancies.
  • The use of laparoscopic surgery in Wilms tumor management is currently very limited.

Conclusions:

  • Wilms tumor management strategies in Europe and the US yield comparable high survival rates.
  • The primary goal in Wilms tumor treatment has shifted towards minimizing long-term therapy-related side effects.
  • Minimally invasive surgical approaches like laparoscopy have a restricted role in current Wilms tumor care.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...